ATS 2023

COVA trial: success for the investigational agent sarconeos in hospitalised COVID-19

Presented By

Dr Girish Balachandran Nair, Beaumont Hospital, MI, USA

Trial

Phase 3, COVA

Conference

ATS 2023

31 May, 2023 08:38

Efficient detection of AECOPD with at-home vital signs monitoring

Presented By

Mr Yann Le Guillou, Biosency, France

Conference

ATS 2023

31 May, 2023 08:36

Improving quality in sepsis through machine learning models

Presented By

Dr Elizabeth Munroe, University of Michigan, MI, USA

Conference

ATS 2023

31 May, 2023 08:34

Mitochondrial DNA predicts COVID-19 severity

Presented By

Dr Marlene Cano, Washington University in Saint Louis, MO, USA

Conference

ATS 2023

31 May, 2023 08:32

Can information technology improve guideline adherence in sepsis care?

Presented By

Dr Daniel Leisman, Massachusetts General Hospital, MA, USA

Conference

ATS 2023

31 May, 2023 08:30

Practice-changing results for ensifentrine in COPD

Presented By

Prof. Antonio Anzueto, University of Texas Health San Antonio, TX, USA

Trial

Phase 3, ENHANCE-1; ENHANCE-2

Conference

ATS 2023

30 May, 2023 11:43

Alvelestat for AATD meets primary endpoints in phase 2 trial

Presented By

Prof. Robert Stockley, University Hospital Birmingham, UK

Trial

Phase 2, ASTRAEUS

Conference

ATS 2023

30 May, 2023 11:42

Fewer exacerbations with dupilumab in COPD with type 2 inflammation

Presented By

Prof. Klaus Rabe, LungenClinic Grosshansdorf GmbH, Germany

Trial

Phase 3, BOREAS

Conference

ATS 2023

30 May, 2023 11:40

New AATD therapy may alleviate treatment burden for patients

Presented By

Dr Brooks Kuhn, UC Davis School of Medicine, CA, USA

Conference

ATS 2023

30 May, 2023 11:39

Remarkable results for novel camel-derived therapy for asthma

Presented By

Dr Benjamin Suratt, Sanofi, NJ, USA

Conference

ATS 2023

30 May, 2023 11:38

Excellent results for C21 in idiopathic pulmonary fibrosis

Presented By

Dr Rohit Batta, Vicore Pharma, Sweden

Trial

Phase 2, AIR

Conference

ATS 2023

25 May, 2023 11:10

May camlipixant improve quality of life of patients with refractory chronic cough?

Presented By

Dr Lorcan McGarvey, Queen’s University Belfast, UK

Trial

Phase 2, SOOTHE

Conference

ATS 2023

25 May, 2023 11:09

Success for fluticasone furoate plus vilanterol in uncontrolled asthma

Presented By

Dr Philippe Bareille, GSK, UK

Conference

ATS 2023

25 May, 2023 11:08

TORREY trial: seralutinib associated with reduced pulmonary vascular resistance in PAH

Presented By

Prof. Robert Frantz, Mayo Clinic, MN, USA

Trial

Phase 2, TORREY

Conference

ATS 2023

25 May, 2023 11:07

Vitamin D for asthma protection: what is the optimal timing?

Presented By

Dr Lourdes Ramirez, Brigham and Women’s hospital, MA, USA

Conference

ATS 2023

25 May, 2023 11:05